Literature DB >> 34942669

Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease.

Tamara K Stevenson1,2, Shannon J Moore1,2, Geoffrey G Murphy1,2, Daniel A Lawrence2,3.   

Abstract

Tissue plasminogen activator's (tPA) fibrinolytic function in the vasculature is well-established. This specific role for tPA in the vasculature, however, contrasts with its pleiotropic activities in the central nervous system. Numerous physiological and pathological functions have been attributed to tPA in the central nervous system, including neurite outgrowth and regeneration; synaptic and spine plasticity; neurovascular coupling; neurodegeneration; microglial activation; and blood-brain barrier permeability. In addition, multiple substrates, both plasminogen-dependent and -independent, have been proposed to be responsible for tPA's action(s) in the central nervous system. This review aims to dissect a subset of these different functions and the different molecular mechanisms attributed to tPA in the context of learning and memory. We start from the original research that identified tPA as an immediate-early gene with a putative role in synaptic plasticity to what is currently known about tPA's role in a learning and memory disorder, Alzheimer's disease. We specifically focus on studies demonstrating tPA's involvement in the clearance of amyloid-β and neurovascular coupling. In addition, given that tPA has been shown to regulate blood-brain barrier permeability, which is perturbed in Alzheimer's disease, this review also discusses tPA-mediated vascular dysfunction and possible alternative mechanisms of action for tPA in Alzheimer's disease pathology. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34942669      PMCID: PMC9175616          DOI: 10.1055/s-0041-1740265

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   6.398


  140 in total

1.  Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.

Authors:  Y F Wang; S E Tsirka; S Strickland; P E Stieg; S G Soriano; S A Lipton
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

2.  Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.

Authors:  Chia-Chen Liu; Jin Hu; Na Zhao; Jian Wang; Na Wang; John R Cirrito; Takahisa Kanekiyo; David M Holtzman; Guojun Bu
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

3.  Tissue-type plasminogen activator triggers the synaptic vesicle cycle in cerebral cortical neurons.

Authors:  Fang Wu; Enrique Torre; David Cuellar-Giraldo; Lihong Cheng; Hong Yi; Edyta K Bichler; Paul S García; Manuel Yepes
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-01       Impact factor: 6.200

4.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

5.  Hindered submicron mobility and long-term storage of presynaptic dense-core granules revealed by single-particle tracking.

Authors:  B A Scalettar; C Jacobs; A Fulwiler; L Prahl; A Simon; L Hilken; J E Lochner
Journal:  Dev Neurobiol       Date:  2012-06-21       Impact factor: 3.964

6.  Localization of brain-derived neurotrophic factor to distinct terminals of mossy fiber axons implies regulation of both excitation and feedforward inhibition of CA3 pyramidal cells.

Authors:  Steve C Danzer; James O McNamara
Journal:  J Neurosci       Date:  2004-12-15       Impact factor: 6.167

7.  Tau suppression in a neurodegenerative mouse model improves memory function.

Authors:  K Santacruz; J Lewis; T Spires; J Paulson; L Kotilinek; M Ingelsson; A Guimaraes; M DeTure; M Ramsden; E McGowan; C Forster; M Yue; J Orne; C Janus; A Mariash; M Kuskowski; B Hyman; M Hutton; K H Ashe
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

8.  Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin.

Authors:  Z L Chen; S Strickland
Journal:  Cell       Date:  1997-12-26       Impact factor: 41.582

9.  Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.

Authors:  Gorka Gerenu; Eva Martisova; Hilda Ferrero; Miguel Carracedo; Tomi Rantamäki; Maria Javier Ramirez; Francisco Javier Gil-Bea
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-26       Impact factor: 5.187

10.  The amyloid hypothesis on trial.

Authors:  Simon Makin
Journal:  Nature       Date:  2018-07       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.